Wedbush analyst Dan Ives is a well-known name in the investing industry. He has been a tech analyst for over two decades and ...

Shift Bioscience, a Cambridge-based biotech company using an AI powered virtual cell to fight age-driven diseases, has ...

Dan Ives, Wedbush Securities, and Bryn Talkington, Requisite Capital, join 'Closing Bell' to discuss Elon Musk's interview ...

Shift Bioscience (Shift), a biotech company using an AI powered virtual cell to fight age-driven diseases, today announced ...

Cambridge biotech company Shift Bioscience, which is using an AI powered virtual cell to fight age-driven diseases, has ...

AI Stocks in Focus Amid U.S.–China Tariff Pause and 10 AI Stocks Making Moves This Week. The U.S. said it will cut tariffs imposed on Chinese imports to 30% from 145% while China said it would cut ...

One of the largest classes in Brevard College history graduated at the 2025 Commencement Ceremony with a total of 171 ...

“He’s been waiting for this his whole life,” Vogt said. “Daniel Schneemann’s a really good baseball player. We’ve been saying it for over a year now. He means so much to this ...

And the quality over quantity approach has its doubters. Wedbush Securities managing director Daniel Ives estimates Apple TV+ has 57 million subscribers, which he called “disappointing.” ...

Tesla (NASDAQ:TSLA) is looking to shake off boardroom drama with Wedbush's Daniel Ives says the leadership dust has finally settled and Elon Musk remains Tesla's undisputed CEO as the automaker ...

Daniel Ives, an analyst at Wedbush Securities, said that it was unlikely that Musk would be replaced as chief executive, although he suggested that tensions between the Tesla board and the ...